Fact CheckerSign in

NCT07221110Completed

rTMS Treatment of Dysphagia in Parkinson's Patients

Effectiveness of Transcranial Magnetic Stimulation on Dysphagia in Patients With Parkinson's Disease: A Randomized Double-Blind Study

Source: ClinicalTrials.gov · Last updated 27 Oct 2025

Brief summary (registry, in English)

The study was conducted with patients with dysphagia who were followed up with Parkinson's disease in the neurology and physical therapy rehabilitation departments. The study is a prospective, double-blind clinical intervention study. Patients were divided into two groups (5 Hz and 10 Hz) and received rTMS (repetitive transcranial magnetic stimulation) treatment. The pharyngeal cortex region was targeted in the intervention. Major aim in the treatment was to examine the difference in clinical response caused by the application of rTMS treatment at different frequencies.

Status (registry)
Completed
Study type
Interventional
Enrollment
26 (actual)
First submitted
22 Oct 2025
Start date
1 Aug 2024
Primary completion date
1 Aug 2025
Lead sponsor
Ege University
NCT number
NCT07221110

What you commit to

  • Study type: Interventional
  • Participants enrolled: 26
  • From 1 Aug 2024 to the primary completion date, 1 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cardiac pace-maker
  • History of seizure
  • Dementia

Other

  • İntracranial metallic device
  • İntracranial lesion on imaging
  • Hydrocephalus
  • Antipsychotic use
  • Babinski positivity
  • Berebellar symptoms
  • Depression

Who the study is looking for

  • Parkinson's disease for more than two years
  • Moderate-to-severe Parkinson's disease (Hoehn yahr 2-4)
  • The patient describing dysphagia symptoms
  • Patients being able to give informed consent.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ege University Hospital
Coordinator of this site? Confirm its status
IzmirTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.